# Study of Nevirapine and Prednisone to Determine the Safety and Effectiveness in Preventing Nevirapine Associated Rash in Human Immunodeficiency Virus (HIV) Infected Patients

> **NCT02184299** · PHASE4 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 138 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Nevirapine
- **DRUG:** Prednisone

## Key facts

- **NCT ID:** NCT02184299
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-04
- **Primary completion:** 2000-01
- **Final completion:** —
- **Target enrollment:** 138 (ACTUAL)
- **Last updated:** 2014-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02184299

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02184299, "Study of Nevirapine and Prednisone to Determine the Safety and Effectiveness in Preventing Nevirapine Associated Rash in Human Immunodeficiency Virus (HIV) Infected Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02184299. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*